Allogene Therapeutics, Inc.
US ˙ NasdaqGS ˙ US0197701065

SecurityALLO / Allogene Therapeutics, Inc.
InstitutionDimensional Fund Advisors Lp
Latest Disclosed Ownership1,201,655 shares
Latest Disclosed Value $ 2,927,439
Dimensional Fund Advisors Lp reports 25.46% increase in ownership of ALLO / Allogene Therapeutics, Inc.

On May 7, 2026 - Dimensional Fund Advisors Lp filed a 13F-HR form disclosing ownership of 1,201,655 shares of Allogene Therapeutics, Inc. (US:ALLO) valued at $2,932,038 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 12, 2026 disclosing 957,816 shares of Allogene Therapeutics, Inc.. This represents a change in shares of 25.46% during the quarter. The current value of the position is $2,259,111 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-07 2026-03-31 13F ALLOGENE THERAPEUTICS COM 019770106 1,201,655 243,839 25.46 2,927 123.26 0.0006
2026-02-12 2025-12-31 13F ALLOGENE THERAPEUTICS COM 019770106 957,816 -1,132,937 -54.19 1,312 -49.42 0.0003
2025-11-12 2025-09-30 13F ALLOGENE THERAPEUTICS COM 019770106 2,090,753 -645,666 -23.60 2,593 -16.17 0.0006
2025-08-12 2025-06-30 13F ALLOGENE THERAPEUTICS COM 019770106 2,736,419 -443,434 -13.95 3,093 -33.41 0.0007
2025-05-13 2025-03-31 13F ALLOGENE THERAPEUTICS COM 019770106 3,179,853 -381,773 -10.72 4,644 -38.79 0.0012
2025-02-13 2024-12-31 13F ALLOGENE THERAPEUTICS COM 019770106 3,561,626 831,146 30.44 7,586 -0.80 0.0018
2024-11-07 2024-09-30 13F ALLOGENE THERAPEUTICS COM 019770106 2,730,480 179,840 7.05 7,647 28.63 0.0019
2024-08-09 2024-06-30 13F ALLOGENE THERAPEUTICS COM 019770106 2,550,640 507,021 24.81 5,944 -34.92 0.0016
2024-05-10 2024-03-31 13F ALLOGENE THERAPEUTICS COM 019770106 2,043,619 508,374 33.11 9,135 85.35 0.0025
2024-02-07 2023-12-31 13F ALLOGENE THERAPEUTICS COM 019770106 1,535,245 -303,111 -16.49 4,928 -15.44 0.0014
2023-11-09 2023-09-30 13F ALLOGENE THERAPEUTICS COM 019770106 1,838,356 546,215 42.27 5,829 -9.21 0.0019
2023-08-09 2023-06-30 13F ALLOGENE THERAPEUTICS COM 019770106 1,292,141 -757,115 -36.95 6,420 -36.59 0.0020
2023-05-12 2023-03-31 13F ALLOGENE THERAPEUTICS COM 019770106 2,049,256 -340,848 -14.26 10,123 67,386.67 0.0034
2023-02-09 2022-12-31 13F ALLOGENE THERAPEUTICS COM 019770106 2,390,104 655,317 37.78 15 -99.92 0.0044
2022-11-10 2022-09-30 13F ALLOGENE THERAPEUTICS COM 019770106 1,734,787 480,099 38.26 18,732 30.94 0.0072
2022-08-12 2022-06-30 13F ALLOGENE THERAPEUTICS COM 019770106 1,254,688 448,701 55.67 14,306 94.80 0.0051
2022-05-13 2022-03-31 13F ALLOGENE THERAPEUTICS COM 019770106 805,987 61,259 8.23 7,344 -33.92 0.0023
2022-02-09 2021-12-31 13F ALLOGENE THERAPEUTICS COM 019770106 744,728 403,573 118.30 11,114 26.76 0.0034
2021-11-12 2021-09-30 13F ALLOGENE THERAPEUTICS COM 019770106 341,155 319,311 1,461.78 8,768 1,438.25 0.0028
2021-08-12 2021-06-30 13F ALLOGENE THERAPEUTICS COM 019770106 21,844 0 0.00 570 -26.07 0.0002
2021-05-14 2021-03-31 13F ALLOGENE THERAPEUTICS COM 019770106 21,844 -23,509 -51.84 771 -32.66 0.0003
2021-03-08 2020-12-31 13F/A-2 ALLOGENE THERAPEUTICS COM 019770106 45,353 -3,195 -6.58 1,145 -37.47 0.0004
2021-02-11 2020-12-31 13F ALLOGENE THERAPEUTICS COM 019770106 45,353 -3,195 1,145 413.5131
2020-11-12 2020-09-30 13F ALLOGENE THERAPEUTICS COM 019770106 48,548 48,548 1,831 0.0008
2020-05-14 2020-03-31 13F ALLOGENE THERAPEUTICS COM 019770106 0 -18,373 -100.00 0 -100.00
2020-02-14 2019-12-31 13F ALLOGENE THERAPEUTICS COM 019770106 18,373 -576 -3.04 477 -7.56 0.0002
2019-11-12 2019-09-30 13F ALLOGENE THERAPEUTICS COM 019770106 18,949 18,949 516 0.0002
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.